Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway.
Saved in:
| Title: | Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway. |
|---|---|
| Authors: | Hu AM; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Chen M; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Zhu CC; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Zhu ZM; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Xu XH; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China.; Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases, Wannan Medical College, Wuhu, 241002, China. |
| Source: | Biochemistry and biophysics reports [Biochem Biophys Rep] 2026 Jan 15; Vol. 45, pp. 102454. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101660999 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5808 (Electronic) Linking ISSN: 24055808 NLM ISO Abbreviation: Biochem Biophys Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
